Answers are grounded in this paper and cite their sources.
Fibrovascular membranes are major causes of vitreous haemorrhage and tractional retinal detachment in proliferative diabetic retinopathy. Although vascular endothelial growth factor drives retinal neovascularisation, membrane formation and contraction also reflect chronic metabolic injury, blood-retinal barrier dysfunction, inflammation, extracellular-matrix remodelling and fibrosis. This review integrates human tissue, single-cell and experimental evidence linking chronic hyperglycaemia to fibrovascular membrane development, distinguishes direct evidence from extrapolation, and evaluates treatment timing and adjunctive strategies that may limit contractile progression while preserving angiogenic control. Polyol-pathway flux, oxidative and carbonyl stress and advanced glycation end-product signalling plausibly contribute to upstream retinal injury, but their activity within human fibrovascular membranes remains poorly demonstrated. Stronger human evidence supports local inflammasome components, matrix metalloproteinase expression, connective tissue growth factor localisation, myeloid heterogeneity and several candidate myofibroblast sources. Hypoxia-responsive and vascular endothelial growth factor-dependent signalling generate the neovascular component, whereas transforming growth factor beta-associated pathways, extracellular-matrix deposition and myofibroblast-like contractility contribute to membrane maturation and traction. The proposed angio-fibrotic switch is best regarded as a testable, context-dependent model rather than a confirmed transition because available human evidence is predominantly cross-sectional and the clinical consequences of fibrosis depend partly on posterior vitreous attachment, macular involvement and membrane configuration. Emerging inflammatory, myeloid, senescence, kinase and long non-coding ribonucleic acid targets remain largely preclinical. Mechanism-based combination strategies should therefore be evaluated in human retinal and membrane models and in clinical studies that incorporate treatment timing and tractional anatomy.
No takes yet. Share an insight, caveat, or question.
Le et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: